Tandem Diabetes Care, Inc. - stock earnings
TNDM Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| Aug. 1, 2024 BeforeMarket | - / - | 203.2 million | - / 206.0 million | 210.3 million |
TNDM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -42.7 million USD | 191.7 million USD |
| 2023Q4 | -30.0 million USD | 196.8 million USD |
| 2023Q3 | -33.0 million USD | 185.6 million USD |
| 2023Q2 | -35.8 million USD | 195.9 million USD |
| 2023Q1 | -123.9 million USD | 169.4 million USD |
| 2022Q4 | -15.9 million USD | 220.5 million USD |
| 2022Q3 | -49.0 million USD | 204.5 million USD |
| 2022Q2 | -15.1 million USD | 200.3 million USD |
| 2022Q1 | -14.7 million USD | 175.9 million USD |
| 2021Q4 | 10.8 million USD | 210.0 million USD |
| 2021Q3 | 5.8 million USD | 179.6 million USD |
| 2021Q2 | 4.0 million USD | 172.1 million USD |
| 2021Q1 | -5.0 million USD | 141.0 million USD |
| 2020Q4 | 17.0 million USD | 168.1 million USD |
| 2020Q3 | -9.4 million USD | 123.6 million USD |
| 2020Q2 | -27.1 million USD | 109.2 million USD |
| 2020Q1 | -14.9 million USD | 97.9 million USD |
| 2019Q4 | 2.7 million USD | 108.4 million USD |
| 2019Q3 | -2.9 million USD | 94.7 million USD |
| 2019Q2 | -1.5 million USD | 93.3 million USD |
| 2019Q1 | -23.0 million USD | 66.0 million USD |
| 2018Q4 | 3.7 million USD | 76.2 million USD |
| 2018Q3 | -34.2 million USD | 46.3 million USD |
| 2018Q2 | -59.4 million USD | 34.1 million USD |
| 2018Q1 | -32.7 million USD | 27.3 million USD |
| 2017Q4 | -11.4 million USD | 40.3 million USD |
| 2017Q3 | -16.0 million USD | 27.0 million USD |
| 2017Q2 | -21.8 million USD | 21.3 million USD |
| 2017Q1 | -23.8 million USD | 19.0 million USD |
| 2016Q4 | -14.8 million USD | 28.9 million USD |
| 2016Q3 | -29.8 million USD | 12.3 million USD |
| 2016Q2 | -18.3 million USD | 23.0 million USD |
| 2016Q1 | -20.5 million USD | 20.1 million USD |
| 2015Q4 | -12.1 million USD | 29.1 million USD |
| 2015Q3 | -19.6 million USD | 15.7 million USD |
| 2015Q2 | -19.5 million USD | 15.7 million USD |
| 2015Q1 | -21.2 million USD | 12.3 million USD |
| 2014Q4 | -18.5 million USD | 17.9 million USD |
| 2014Q3 | -19.9 million USD | 13.5 million USD |
| 2014Q2 | -19.2 million USD | 10.3 million USD |
| 2014Q1 | -22.0 million USD | 8.1 million USD |
| 2013Q4 | -23.6 million USD | 10.2 million USD |
| 2013Q3 | -13.1 million USD | 7.8 million USD |
| 2013Q2 | -15.3 million USD | 5.5 million USD |
| 2013Q1 | -11.2 million USD | 5.5 million USD |
| 2012Q4 | -8.6 million USD | 2.3 million USD |
| 2012Q3 | -7.5 million USD | 217727 USD |
TNDM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -222.6 million USD | 747.7 million USD |
| 2022 | -94.6 million USD | 801.2 million USD |
| 2021 | 15.6 million USD | 702.8 million USD |
| 2020 | -34.4 million USD | 498.8 million USD |
| 2019 | -24.8 million USD | 362.3 million USD |
| 2018 | -122.6 million USD | 183.9 million USD |
| 2017 | -73.0 million USD | 107.6 million USD |
| 2016 | -83.4 million USD | 84.2 million USD |
| 2015 | -72.4 million USD | 72.9 million USD |
| 2014 | -79.5 million USD | 49.7 million USD |
| 2013 | -63.1 million USD | 29.0 million USD |
| 2012 | -33.0 million USD | 2.5 million USD |
| 2011 | -25.5 million USD | ? USD |
TNDM
Price: $51.73
52 week price:
Earnings Per Share: -3.43 USD
P/E Ratio: -7.26
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Volume: 448000
Ebitda: -11.4 millionMarket Capitalization: 2.8 billion